GeneDx Appoints Bryan Dechairo as Chief Operating Officer GeneDx (Nasdaq: WGS), a leader in advancing health outcomes through genomic insights, has announced the appointment of Bryan Dechairo as Chief Operating Officer (COO), effective immediately. In this newly created role, Dechairo…
Certification Achieved by ModMed for AI-Powered Scribe by ASTP/ONC ModMed®, a leading innovator in healthcare technology, announced that its electronic health records (EHR) platform, EMA®, has successfully achieved certification from the Assistant Secretary for Technology Policy/Office of the National Coordinator…
Therapies: PharmaEssentia Ensures Reliable Interferon Access PharmaEssentia (TWSE: 6446), a leading global biopharmaceutical company, has reaffirmed its commitment to ensuring robust and reliable access to critical interferon therapies, particularly in light of the reported global shortage of Pegasys® (peginterferon alfa-2a).…
Voom CEO Dr. Neal Blitz Guest Edits January 2025 Clinics in Podiatric Medicine Issue on MIS Voom™ Medical Devices, Inc. (“Voom”), a pioneering company revolutionizing minimally invasive foot and ankle surgery, is excited to announce that its Founder and CEO,…
TruBridge Appoints Merideth Wilson as GM of Financial Health TruBridge, Inc. (NASDAQ: TBRG), a leading provider of healthcare solutions, has announced the appointment of Merideth Wilson as the new Financial Health General Manager. TruBridge appoints Wilson to this important role…
Merz Group Unveils New OTC Business Player for the New Year At the turn of the year, Merz Lifecare and WindStar Medical completed their merger, resulting in the formation of a joint holding company. The two OTC businesses will now…
Invests $150M in Patho Care via PathoCare Holdings, Hamershlag Private Capital Hamershlag Private Capital Management Limited (HPCM), a prominent health technology investment firm, invests in Patho Care, LLC, a leading innovator in non-invasive point-of-care diagnostic testing. Patho Care’s groundbreaking Raman…
Elation Health Expands Leadership Team, Welcomes New COO and President Elation Health, a technology company focused on transforming primary care, has announced a series of significant milestones, marking a record-setting year for the company. Among the highlights, Elation has appointed…
Analgesic from Xgene Pharmaceutical Reduces Pain and Opioid Use in Post-Surgical Trial Xgene Pharmaceutical has revealed further findings from a positive, multi-center, placebo-controlled, dose-ranging Phase 2b study (registration number: NCT06017999) evaluating the safety and efficacy of its XG005 oral tablet…
OS Therapies Completes $6 Million Private Placement OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company specializing in cancer immunotherapy and antibody-drug conjugates, today announced the successful completion of a private placement financing, raising approximately $6 million in gross proceeds.…